Investor Details
| Filer Name: | SOFINNOVA INVESTMENTS, INC. |
|---|---|
| CIK: | 1631134 |
| Period: | 2024-12-31 |
| Filed At: | 2025-02-14 |
| Number of Holdings: | 61 |
| Portfolio Value: | $1.37B |
Sofinnova Investments, Inc. Top Holdings
| Ticker | Exchange | Security | Shares | Value | % of Portfolio | Position Change | Put/Call |
|---|---|---|---|---|---|---|---|
| NTRA | US | NATERA INC | 1,550,280 | $245M | 17.88% | - | - |
| VERA | US | VERA THERAPEUTICS INC | 2,793,987 | $118M | 8.61% | - | - |
| GILD | US | GILEAD SCIENCES INC | 774,227 | $72M | 5.21% | 100.0% | - |
| ABBV | US | ABBVIE INC | 359,393 | $64M | 4.65% | 100.0% | - |
| JAZZ | US | JAZZ PHARMACEUTICALS PLC | 504,193 | $62M | 4.52% | 167.4% | - |
| SRPT | US | SAREPTA THERAPEUTICS INC | 428,771 | $52M | 3.80% | 100.0% | - |
| AVBP | US | ARRIVENT BIOPHARMA INC | 1,696,752 | $45M | 3.29% | - | - |
| AZN | US | ASTRAZENECA PLC-SPONS ADR | 651,344 | $43M | 3.11% | -19.5% | - |
| SYK | US | STRYKER CORP | 116,005 | $42M | 3.04% | 100.0% | - |
| AXSM | US | AXSOME THERAPEUTICS INC | 491,726 | $42M | 3.03% | 29.6% | - |
| REPL | US | REPLIMUNE GROUP INC | 3,149,522 | $38M | 2.78% | 6442.7% | - |
| INCY | US | INCYTE CORP | 524,267 | $36M | 2.64% | -26.6% | - |
| RAPP | US | RAPPORT THERAPEUTICS INC | 1,995,594 | $35M | 2.58% | - | - |
| SLNO | US | SOLENO THERAPEUTICS INC | 757,248 | $34M | 2.48% | 152.4% | - |
| BSX | US | BOSTON SCIENTIFIC CORP | 346,571 | $31M | 2.25% | 155.2% | - |
| IDYA | US | IDEAYA BIOSCIENCES INC | 1,069,090 | $27M | 2.00% | -38.9% | - |
| ALNY | US | ALNYLAM PHARMACEUTICALS INC | 110,157 | $26M | 1.89% | 100.0% | - |
| ALKS | US | ALKERMES PLC | 894,266 | $26M | 1.87% | 100.0% | - |
| DYN | US | DYNE THERAPEUTICS INC | 1,071,498 | $25M | 1.84% | 38.8% | - |
| DXCM | US | DEXCOM INC | 290,210 | $23M | 1.64% | 100.0% | - |